Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
In vitro Mutagenesis01:16

In vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The EU chemicals strategy for sustainability: in support of the BfR position.

Archives of toxicology·2021
Same author

Corrigendum to "Critique of the "Comment" etitled "Pyrethroid exposure: not so harmless after all" by Demeneix et al. (2020) published in the lancet diabetes endocrinology".

Toxicology letters·2021
Same author

Critique of the "Comment" etitled "Pyrethroid exposure: Not so harmless after all" by Demeneix et al. (2020) published in the lancet diabetes endocrinology.

Toxicology letters·2021
Same author

Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?

Journal of toxicology and environmental health. Part A·2020
Same author

Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity: how to evaluate the risk of the S-EDCs?

Archives of toxicology·2020
Same author

Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?

Environmental toxicology and pharmacology·2020

Related Experiment Video

Updated: Jun 16, 2026

Eye Irritation Test (EIT) for Hazard Identification of Eye Irritating Chemicals using Reconstructed Human Cornea-like Epithelial (RhCE) Tissue Model
10:13

Eye Irritation Test (EIT) for Hazard Identification of Eye Irritating Chemicals using Reconstructed Human Cornea-like Epithelial (RhCE) Tissue Model

Published on: August 23, 2015

Validating and troubleshooting ocular in vitro toxicology tests.

Frank A Barile1

  • 1Department of Pharmaceutical Sciences, Toxicology Division, St. John's University, College of Pharmacy and Allied Health Professions, Queens, New York 11439, USA. barilef@stjohns.edu

Journal of Pharmacological and Toxicological Methods
|January 26, 2010
PubMed
Summary

In vitro organotypic models offer promising alternatives to animal testing for ocular irritants. These methods quantitatively assess corneal opacity and permeability to predict in vivo irritation potential.

More Related Videos

Determining the Toxicity of UV Radiation and Chemicals on Primary and Immortalized Human Corneal Epithelial Cells
09:31

Determining the Toxicity of UV Radiation and Chemicals on Primary and Immortalized Human Corneal Epithelial Cells

Published on: July 22, 2021

Related Experiment Videos

Last Updated: Jun 16, 2026

Eye Irritation Test (EIT) for Hazard Identification of Eye Irritating Chemicals using Reconstructed Human Cornea-like Epithelial (RhCE) Tissue Model
10:13

Eye Irritation Test (EIT) for Hazard Identification of Eye Irritating Chemicals using Reconstructed Human Cornea-like Epithelial (RhCE) Tissue Model

Published on: August 23, 2015

Determining the Toxicity of UV Radiation and Chemicals on Primary and Immortalized Human Corneal Epithelial Cells
09:31

Determining the Toxicity of UV Radiation and Chemicals on Primary and Immortalized Human Corneal Epithelial Cells

Published on: July 22, 2021

Area of Science:

  • Ophthalmology
  • Toxicology
  • In Vitro Testing

Background:

  • In vitro organotypic models are gaining traction as replacements for in vivo ocular testing.
  • These models aim to preserve short-term physiological and biochemical functions of the mammalian cornea in an isolated system.

Purpose of the Study:

  • To review and discuss various in vitro organotypic models for ocular irritancy and corrosion assessment.
  • To highlight methodologies, protocol details, applications, and validation status of these models.
  • To emphasize improvements and troubleshooting for standalone in vitro ocular toxicity assessment.

Main Methods:

  • Quantitative measurements of corneal opacity (opacitometry) and permeability (spectrophotometry) to assess damage.
  • Discussion of specific models: Bovine Corneal Opacity and Permeability (BCOP) assay, Isolated Chicken Eye (ICE) test, Isolated Rabbit Eye (IRE) assay, and Hen's Egg Test-Chorioallantoic Membrane (HET-CAM) assay.
  • Review of historical development and current validation status of in vitro ocular testing models.

Main Results:

  • Several in vitro models, including BCOP, ICE, IRE, and HET-CAM, are presented as viable alternatives for ocular irritancy testing.
  • These models utilize quantitative measurements to predict in vivo ocular irritation potential.
  • The need for further refinement to establish these models as standalone tools is indicated.

Conclusions:

  • In vitro organotypic models provide valuable data for assessing ocular irritation and corrosion.
  • Continued research and validation are crucial for their widespread adoption as replacements for in vivo testing.
  • Optimizing current techniques will enhance their utility in ocular toxicity assessment.